Tourmaline Bio, Inc.

NASDAQ (USD): Tourmaline Bio, Inc. (TRML)

Last Price

21.84

Today's Change

+0.445 (2.07%)

Day's Change

21.01 - 21.86

Trading Volume

88,466

Profile
TRML

Exchange:  NASDAQ Global Select NASDAQ Global Select

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Sandeep C. Kulkarni M.D. Dr. Sandeep C. Kulkarni M.D.

Full Time Employees:  74 74

IPO Date:  2021-05-07 2021-05-07

CIK:  0001827506 0001827506

ISIN:  US89157D1054 US89157D1054

CUSIP: 

Beta:  0.00 0.00

Last Dividend:  0.00 0.00

Dcf Diff:  -8.08 -8.08

Dcf:  29.56 29.56

Description

Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.

Address

27 West 24th Street,
New York, NY 10010, US

646-481-9832

http://www.tourmalinebio.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment